Pfizer says Lyme disease vaccine shows promise
Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease.
Watch CBS News
Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease.
As temperatures rise, so do the number of ticks and the risk of Lyme disease. But the good news is an effective Lyme Disease vaccine is on the horizon.
Moderna's CEO defended a plan to more than quadruple the company's COVID-19 vaccine price,
Zavzpret, a nasal spray created by Pzifer, is expected to go on the market in July.
Hope is on the horizon for parents and providers who are unfortunately familiar with the frightening respiratory virus RSV. WBZ-TV's Juli McDonald reports.
WBZ TV's Dr. Mallika Marshall said there's no reason to be concerned about the bivalent booster shot.
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday.
Pfizer is asking the FDA to authorize its improved COVID shots. WBZ-TV's Chris Tanaka reports.
Results of the trial showed that the vaccine appeared to be safe and had a strong immune response.
The vaccine would be a three-dose regimen for younger kids.
WBZ-TV's Dr. Mallika Marshall has more on this breaking story.
WBZ TV's Breana Pitts reports.
Pfizer said new data shows its kid-sized booster could help healthy elementary-aged children rev up virus-fighting antibodies.
The US Food and Drug Administration has expanded the emergency use authorization of the Pfizer and Moderna Covid-19 vaccines to allow adults age 50 and older.
The recall is voluntary and stems from the tablets containing higher levels of nitrosamines, which pose a cancer risk.
Parents will have to keep waiting to find out when their youngest children can get a Covid-19 vaccine.
Pfizer has asked the FDA to authorize extra-low doses of its COVID-19 vaccine for children under 5.
The Food and Drug Administration is now allowing Pfizer booster shots for kids as young as 12. The next step will be CDC approval.
The FDA is reportedly expected to broaden eligibility for Pfizer COVID-19 vaccine boosters to kids ages 12 to 15 in the coming days.
This is the first antiviral Covid-19 pill authorized for ill people to take at home, before they get sick enough to be hospitalized.
Pfizer said the pill cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms.
Pfizer announced Wednesday that a third dose of its vaccine will likely protect people from the Omicron variant.
The FDA on Friday authorized Moderna and Pfizer's COVID vaccine booster shots for all adults 18 and older.
Massachusetts is opening up COVID booster shots to any fully vaccinated resident age 18 or older, effective immediately.
The Pfizer COVID booster shot could be available to all adults by the end of this week.
